Pediatrix Medical Group, Inc. (MD) earnings per share

Next earnings report (estimated)
2026-08-04
Pending company confirmation.
Consensus EPS
$0.59
7 analysts · Range $0.57 – $0.62
Annual history
Fiscal years 2010 – 2025
USD / SHARE 18 PERIODS
Period End Diluted Filed
FY 2025 2025-12-31 $1.94 2026-02-19
FY 2024 2024-12-31 -$1.19 2025-02-20
FY 2023 2023-12-31 -$0.73 2024-02-20
FY 2022 2022-12-31 $0.79 2023-02-17
FY 2021 2021-12-31 $1.53 2022-02-17
FY 2020 2020-12-31 -$9.55 2021-02-18
FY 2019 2019-12-31 -$17.83 2020-02-20
FY 2018 2018-12-31 $2.93 2019-02-14
FY 2017 2017-12-31 $3.45 2018-02-14
FY 2016 2016-12-31 $3.49 2017-02-10
FY 2015 2015-12-31 $3.58 2016-02-11
FY 2014 2014-12-31 $3.18 2015-02-09
FY 2013 2013-12-31 $2.78 2014-02-12
FY 2012 2012-12-31 $2.42 2013-02-15
FY 2011 2011-12-31 $2.23 2012-02-29
FY 2010 2010-12-31 $2.13 2011-02-24
FY 2010 2009-12-31 $1.89 2011-02-24
FY 2010 2008-12-31 $1.79 2011-02-24
Quarterly history
Fiscal years 2010 – 2026
USD / SHARE 68 PERIODS
Period End Diluted Filed
Q1 2026 2026-03-31 $0.36 2026-05-05
Q4 2025 2025-12-31 $0.40 2026-02-19
Q3 2025 2025-09-30 $0.84 2025-11-03
Q2 2025 2025-06-30 $0.46 2025-08-05
Q1 2025 2025-03-31 $0.24 2025-05-06
Q4 2024 2024-12-31 $0.37 2025-02-20
Q3 2024 2024-09-30 $0.23 2024-11-01
Q2 2024 2024-06-30 -$1.84 2024-08-06
Q1 2024 2024-03-31 $0.05 2024-05-07
Q4 2023 2023-12-31 -$1.50 2024-02-20
Q3 2023 2023-09-30 $0.26 2023-11-02
Q2 2023 2023-06-30 $0.34 2023-08-03
Q1 2023 2023-03-31 $0.17 2023-05-02
Q4 2022 2022-12-31 $0.36 2023-02-17
Q3 2022 2022-09-30 $0.37 2022-11-03
Q2 2022 2022-06-30 $0.32 2022-08-04
Q1 2022 2022-03-31 -$0.25 2022-04-28
Q4 2021 2021-12-31 $0.56 2022-02-17
Q3 2021 2021-09-30 $0.36 2021-10-28
Q2 2021 2021-06-30 $0.41 2021-08-06
Q1 2021 2021-03-31 $0.21 2021-05-07
Q4 2020 2020-12-31 -$0.76 2021-02-18
Q3 2020 2020-09-30 -$0.49 2020-11-06
Q2 2020 2020-06-30 -$8.03 2020-07-30
Q1 2020 2020-03-31 -$0.22 2020-05-07
Q4 2019 2019-12-31 $0.11 2020-02-20
Q3 2019 2019-09-30 -$15.15 2019-11-01
Q2 2019 2019-06-30 -$0.10 2019-08-01
Q1 2019 2019-03-31 -$2.81 2019-05-02
Q4 2018 2018-12-31 $0.68 2019-02-14
Q3 2018 2018-09-30 $0.72 2018-11-01
Q2 2018 2018-06-30 $0.85 2018-08-02
Q1 2018 2018-03-31 $0.68 2018-05-04
Q4 2017 2017-12-31 $1.46 2018-02-14
Q3 2017 2017-09-30 $0.71 2017-11-01
Q2 2017 2017-06-30 $0.69 2017-07-28
Q1 2017 2017-03-31 $0.59 2017-05-04
Q4 2016 2016-12-31 $0.84 2017-02-10
Q3 2016 2016-09-30 $1.04 2016-10-27
Q2 2016 2016-06-30 $0.89 2016-07-28
Q1 2016 2016-03-31 $0.73 2016-04-28
Q4 2015 2015-12-31 $0.99 2016-02-11
Q3 2015 2015-09-30 $0.97 2015-10-29
Q2 2015 2015-06-30 $0.90 2015-07-30
Q1 2015 2015-03-31 $0.72 2015-04-30
Q4 2014 2014-12-31 $0.89 2015-02-09
Q3 2014 2014-09-30 $0.86 2014-10-30
Q2 2014 2014-06-30 $0.79 2014-07-31
Q1 2014 2014-03-31 $0.63 2014-05-01
Q4 2013 2013-12-31 $0.78 2014-02-12
Q3 2013 2013-09-30 $0.76 2013-10-31
Q2 2013 2013-06-30 $0.68 2013-07-30
Q1 2013 2013-03-31 $0.55 2013-05-02
Q4 2012 2012-12-31 $0.66 2013-02-15
Q3 2012 2012-09-30 $0.66 2012-11-01
Q2 2012 2012-06-30 $0.61 2012-07-31
Q1 2012 2012-03-31 $0.49 2012-05-03
Q4 2011 2011-12-31 $0.59 2012-02-29
Q3 2011 2011-09-30 $0.59 2011-11-01
Q2 2011 2011-06-30 $0.57 2011-08-02
Q1 2011 2011-03-31 $0.47 2011-05-03
Q4 2010 2010-12-31 $0.56 2011-02-24
Q3 2010 2010-09-30 $0.65 2010-11-03
Q2 2010 2010-06-30 $0.52 2010-08-31
Q1 2011 2010-03-31 $0.41 2011-05-03
Q4 2010 2009-12-31 $0.54 2011-02-24
Q3 2010 2009-09-30 $0.52 2010-11-03
Q2 2010 2009-06-30 $0.93 2010-08-31

Methodology

Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (2 split s since 2006).

For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.

MD CIK 0000893949 Source: EDGAR filings · all facts

Related tickers

RARE

ULTRAGENYX PHARMACEUTICAL INC.

ARVN

ARVINAS, INC.

HAIN

THE HAIN CELESTIAL GROUP, INC.